TABLE OF CONTENTS
1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW 27
1.4 LIMITATIONS 28
1.5 MARKETS COVERED 28
2 MARKET SEGMENTATION 32
2.1 MARKETS COVERED 32
2.2 GEOGRAPHICAL SCOPE 33
2.3 YEARS CONSIDERED FOR THE STUDY 34
2.4 CURRENCY AND PRICING 34
2.5 DBMR TRIPOD DATA VALIDATION MODEL 35
2.6 TYPE LIFE LINE CURVE 38
2.7 MULTIVARIATE MODELING 39
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 40
2.9 DBMR MARKET POSITION GRID 41
2.10 MARKET APPLICATION COVERAGE GRID 42
2.11 DBMR MARKET CHALLENGE MATRIX 43
2.12 DBMR VENDOR SHARE ANALYSIS 44
2.13 SECONDARY SOURCES 45
2.14 ASSUMPTIONS 46
3 EXECUTIVE SUMMARY 47
4 PREMIUM INSIGHTS 50
4.1 ADDITIONAL CUSTOMIZATIONS 52
4.1.1 PRODUCTION CAPACITY BY MAJOR COUNTRIES 52
4.1.2 NEEM OILS' PRICE FROM PRODUCERS TO TRADERS ANALYSIS 52
4.1.3 NEEM OILS AS BIOFUELS 54
4.1.4 LIST OF MANUFACTURERS 54
4.1.5 PRICE ANALYSIS 55
5 MARKET OVERVIEW 56
5.1 DRIVERS 58
5.1.1 GROWING DEMAND FOR ORGANIC PRODUCTS 58
5.1.2 INCREASING APPLICATION OF NEEM OIL CONCENTRATES IN THE AGRICULTURE INDUSTRY 59
5.1.3 EXPANSION OF END-USE INDUSTRIES FOR NEEM OIL CONCENTRATES 60
5.2 RESTRAINTS 61
5.2.1 AVAILABILITY OF SUBSTITUTES 61
5.2.2 REGULATORY HURDLES AND QUALITY CONTROL 61
5.3 OPPORTUNITIES 62
5.3.1 POTENTIAL APPLICATIONS IN AUTOMOTIVE INDUSTRY 62
5.3.2 NEW PRODUCT DEVELOPMENT AND DIVERSIFICATION 63
5.4 CHALLENGES 64
5.4.1 LIMITED AWARENESS OF NEEM OIL AND CONCENTRATES 64
5.4.2 LIMITED AVAILABILITY AND SUPPLY CHAIN CHALLENGES 64
6 MIDDLE EAST & AFRICA NEEM OIL AND CONCENTRATES MARKET, BY REGION 66
6.1 MIDDLE EAST AND AFRICA 67
6.1.1 SOUTH AFRICA 74
6.1.2 EGYPT 77
6.1.3 SAUDI ARABIA 80
6.1.4 ISRAEL 83
6.1.5 UNITED ARAB EMIRATES 86
6.1.6 REST OF MIDDLE EAST AND AFRICA 89
7 MIDDLE EAST & AFRICA NEEM OIL AND CONCENTRATES MARKET: COMPANY LANDSCAPE 90
7.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 90
7.2 PARTNERSHIP 91
7.3 CERTIFICATIONS 91
7.4 ACQUISITION 92
7.5 NEW PLANT 92
8 SWOT ANALYSIS 93
9 COMPANY PROFILES 94
9.1 SPECTRUM BRANDS, INC. 94
9.1.1 COMPANY SNAPSHOT 94
9.1.2 REVENUE ANALYSIS 94
9.1.3 COMPANY SHARE ANALYSIS 95
9.1.4 PRODUCT PORTFOLIO 95
9.1.5 RECENT DEVELOPMENT 95
9.2 MURUGAPPA GROUP 96
9.2.1 COMPANY SNAPSHOT 96
9.2.2 REVENUE ANALYSIS 96
9.2.3 COMPANY SHARE ANALYSIS 97
9.2.4 PRODUCT PORTFOLIO 97
9.2.5 RECENT DEVELOPMENT 97
9.3 SBM COMPANY (NATRIA) 98
9.3.1 COMPANY SNAPSHOT 98
9.3.2 COMPANY SHARE ANALYSIS 98
9.3.3 PRODUCT PORTFOLIO 99
9.3.4 RECENT DEVELOPMENTS 99
9.4 CONNOILS LLC 100
9.4.1 COMPANY SNAPSHOT 100
9.4.2 COMPANY SHARE ANALYSIS 100
9.4.3 PRODUCT PORTFOLIO 101
9.4.4 RECENT DEVELOPMENT 101
9.5 MANORAMA INDUSTRIES LIMITED 102
9.5.1 COMPANY SNAPSHOT 102
9.5.2 REVENUE ANALYSIS 102
9.5.3 COMPANY SHARE ANALYSIS 103
9.5.4 PRODUCT PORTFOLIO 103
9.5.5 RECENT DEVELOPMENT 103
9.6 AROMANTIC NATURAL SKIN CARE 104
9.6.1 COMPANY SNAPSHOT 104
9.6.2 PRODUCT PORTFOLIO 104
9.6.3 RECENT DEVELOPMENT 104
9.7 BONIDE PRODUCTS LLC 105
9.7.1 COMPANY SNAPSHOT 105
9.7.2 PRODUCT PORTFOLIO 105
9.7.3 RECENT DEVELOPMENT 105
9.8 DYNO-GRO, INC 106
9.8.1 COMPANY SNAPSHOT 106
9.8.2 PRODUCT PORTFOLIO 106
9.8.3 RECENT DEVELOPMENT 106
9.9 GREENWAY BIOTECH 107
9.9.1 COMPANY SNAPSHOT 107
9.9.2 PRODUCT PORTFOLIO 107
9.9.3 RECENT DEVELOPMENT 107
9.10 MYCSA AG 108
9.10.1 COMPANY SNAPSHOT 108
9.10.2 PRODUCT PORTFOLIO 108
9.10.3 RECENT DEVELOPMENT 108
9.11 NOW FOODS 109
9.11.1 COMPANY SNAPSHOT 109
9.11.2 PRODUCT PORTFOLIO 109
9.11.3 RECENT DEVELOPMENT 109
9.12 OZONE BIOTECH 110
9.12.1 COMPANY SNAPSHOT 110
9.12.2 PRODUCT PORTFOLIO 110
9.12.3 RECENT DEVELOPMENT 110
9.13 PF HARRIS 111
9.13.1 COMPANY SNAPSHOT 111
9.13.2 PRODUCT PORTFOLIO 111
9.13.3 RECENT DEVELOPMENT 111
9.14 SUN BIONATURALS 112
9.14.1 COMPANY SNAPSHOT 112
9.14.2 PRODUCT PORTFOLIO 112
9.14.3 RECENT DEVELOPMENT 112
9.15 SUNSHIV BOTANICS 113
9.15.1 COMPANY SNAPSHOT 113
9.15.2 PRODUCT PORTFOLIO 113
9.15.3 RECENT DEVELOPMENT 113
9.16 VEDAOILS.COM 114
9.16.1 COMPANY SNAPSHOT 114
9.16.2 PRODUCT PORTFOLIO 114
9.16.3 RECENT DEVELOPMENT 114
9.17 WOODSTREAM CORPORATION 115
9.17.1 COMPANY SNAPSHOT 115
9.17.2 PRODUCT PORTFOLIO 115
9.17.3 RECENT DEVELOPMENT 116
10 QUESTIONNAIRE 117
11 RELATED REPORTS 119

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.